Time to face the foul facts, America. To profit amid our economic pain you may have no choice but to dive headlong into the muck.   Read More

Burlington Northern, the railroad in which Warren Buffet owns at 20% stake, reported its highest profits ever on Tuesday. Is trading in Buffet’s wake your ticket to ride?   Read More

Wall Street’s on the edge of its seat ahead of Wednesday’s interest-rate announcement. You should be on the phone with your broker.   Read More

It's a big day for pipeline progress...or not. Late Friday, Merck and Schering-Plough announced that the Food and Drug Administration won't approve their combo Claritin-Singulair combo pill for allergies.    Read More

The Dow pulled back Monday after a weaker-than-expected profit report from Bank of America stirred concerns about the health of corporate earnings. What's the "Word on The Street?"   Read More

Intel shares gapped higher after hours on guidance, setting up for a higher market open Tuesday. Also, a breakdown of the oil trade, CSX earnings and more.    Read More

Dow component and healthcare conglomerate (drugs, consumer products, medical devices) Johnson & Johnson beat and boosted. That's Wall Street jargon for earnings coming in higher than expectations and the guidance for the rest of the year being raised. So, why did the stock go down?    Read More

Futures actually moved up at 8:30 ET, despite PPI much stronger than anticipated (core PPI was in-line, apparently because car and truck prices were dropping; the NY Empire State Index was stronger than expected).    Read More

In Monday’s Web Extra the traders reveal how to play Johnson & Johnson, CSX Corp. as well as a second airline merger.   Read More

Can we please get some upside earnings reports this quarter? No financial exposure here. Instead, this Dow Industrial has plenty of overseas business to be helped by the weaker dollar and guardedly optimistic expectations for key business segments.   Read More